Buy On Lazada

Buy on Qoo10

Buy on SHOPEE

Join us as a reseller WITHIN SINGAPORE

• Description
• Specifications
• Request

<

>

Maverick the All-Rounder nitrile glove has proven itself in medical, laboratory and industrial use. Tested for tensile strength and chemical resistance, Maverick’s elastic formulation mimics the donning properties of latex gloves in softness, stretchability, tactility and comfort fitting. Maverick is also tested to be food safe and is a favourite within the food & beverage industry.

      Features:

• Fingertip textured
• Powder free
• Food safe
• Not made with natural rubber latex
• Chemo drugs tested
• Lab chemical tested
• Ambidextrous
• Standard cuff

    Sizes

• X-Small
• Small
• Medium
• Large
• X-Large

Packaging Information
100 Gloves per box
10 Boxes per carton

Dimensions in millimetres.

Glove Properties	Measurement (mm)
Length (mm)	≥ 230
Thickness at Palm (centre of Palm)	​0.08 ± 0.02
Thickness at Finger (13mm ± 3mm from tip)	​0.11 ± 0.02

Physical Properties	Before Ageing	After Ageing
Tensile Strength (MPa)	≥ 18	≥ 16
Elongation (%)	≥ 500	≥ 400

Chemical	EN 16523-1:2015 Permeation Level	EN 374-4:2013 Mean Degradation (%)
K    40% Sodium Hydroxide	6	3.2
P    30% Hydrogen Peroxide	2	​26.9
T     37% Formaldehyde	​5	13.8

Inspection Levels & AQL	Inspection Level	AQL
Watertightness	G1	1.5
Physical Dimensions	S2	4.0
Tensile Strength	S2	4.0
Visual Inspection (Major)	S4	2.5
Visual Inspection (Minor)	S4	4.0
Particulate Residue	N = 5	≤ 2mg/glove

Measured breakthrough time (Minutes)	Permeation performance level
>10	1
>30	2
>60	3
>120	4
>240	5
>480	6

REGULATORY COMPLIANCE	STANDARDS	MANUFACTURING ACCREDITATION
TGA - ARTG 164563 EC 1935/2004 EC 10/2011 EU 10/2011 EU 2016/425 FDA 510(k) MDR (EU) 2017/745 REACH ROHS Directive 2002/95/EC	ASTM D5151 ASTM D6319 ASTM D6978 ASTM D6124 CEN/TS 14234 EN 374 part 1 (Type B), 2, 4 & 5  EN 455 part 1, 2, 3, 4 ISO 10993-10 ISO 10993-5	ISO 9001 ISO 13485 EN ISO 13485

Chemotherapy Drugs and Concentration (Tested for Resistance to Permeation by Chemotherapy Drugs as per ASTM D6978-05-Test Report PN 104145B)	Minimum Breakthrough Detection Time (minutes)
Carmustine (BCNU), 3.3mg/ml (3,300 ppm)	15.3 minutes
Cisplatin, 1.0mg/ml (1,000 ppm)	> 240 minutes
Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000 ppm)	> 240 minutes
Dacarbazine (DTIC), 10.0mg/ml (10,000 ppm)	> 240 minutes
Doxorubicin Hydrochloride, 2.0mg/ml (2,000 ppm)	> 240 minutes
Etoposide (Toposar), 20.00mg/ml (20,000 ppm)	> 240 minutes
Fluorouracil, 50.0mg/ml (50,000 ppm)	> 240 minutes
Methotrexate, 25.0mg/ml (25,000 ppm)	> 240 minutes
Mitomycin C, 0.5mg/ml (500 ppm)	> 240 minutes
Paclitaxel (Taxol), 6.0mg/ml (6,000 ppm)	> 240 minutes
Thiotepa, 10.0mg/ml (10,000 ppm)	46.3 minutes
Vincristine Sulfate, 1.0mg/ml (1,000 ppm)	> 240 minutes

Videos